Core Viewpoint - Zhenghai Biological reported a decline in both revenue and net profit for the third quarter of 2025, indicating potential challenges in its financial performance [1] Financial Performance - In Q3 2025, the company achieved a revenue of 87.87 million yuan, a year-on-year decrease of 5.84% [1] - The net profit attributable to shareholders for Q3 2025 was 20.92 million yuan, reflecting a significant year-on-year decline of 46.4% [1] - For the first three quarters of 2025, the company reported a total revenue of 276 million yuan, down 5.36% compared to the same period last year [1] - The net profit attributable to shareholders for the first three quarters of 2025 was 67.40 million yuan, also showing a decline of 46.1% year-on-year [1]
正海生物2025年第三季度净利润同比下降46.4%